HWC Stock Analysis: Hancock Whitney | NASDAQ
Banks - Regional | NASDAQ, USA | Market Cap: 5.902m USD | 12M Return: 20.6% | US4101201097 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 55.8M
EPS Trend: 71.4%
Qual. Beats: 0
Rev. Trend: 51.2%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Hancock Whitney Corporation is a financial holding company that operates Hancock Whitney Bank, serving commercial, small business, and retail customers across the United States through both traditional and online channels. Its offerings span deposit products (including brokered deposits, time deposits, and money market accounts), treasury management services, secured and unsecured loans, letters of credit, trust and investment management, and investment advisory and brokerage services.
The companys lending portfolio covers commercial and industrial loans, construction and land development loans, residential mortgages, and a range of consumer loans such as home equity lines of credit, auto, recreational vehicle and boat financing, and a small credit card portfolio. Beyond core banking, Hancock Whitney provides commercial finance (including leases) to middle-market and corporate clients, fixed annuity and life insurance products, and underwriting services for debt and mortgage-related securities. Founded in 1899 and headquartered in Gulfport, Mississippi, the company operates as a mid-cap regional bank within the U.S. Gulf South region, with its business model diversified across commercial banking, consumer lending, wealth management, and insurance.
- Net interest margin expansion on elevated Fed funds rate
- Energy sector lending grows with Gulf Coast production activity
- Commercial real estate loan concentration raises credit risk concerns
| Net Income: 427.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA -0.08 > 1.0 |
| NWC/Revenue: -7.08% < 20% (prev 293.4%; Δ -300.5% < -1%) |
| CFO/TA 0.02 > 3% & CFO 577.4m > Net Income 427.4m |
| Net Debt (785.4m) to EBITDA (578.1m): 1.36 < 3 |
| Current Ratio: 0.91 > 1.5 & < 3 |
| Outstanding Shares: last quarter (81.5m) vs 12m ago -5.47% < -2% |
| Gross Margin: 72.93% > 18% (prev 69.96%; Δ 2.97% > 0.5%) |
| Asset Turnover: 5.48% > 50% (prev 5.72%; Δ -0.25% > 0%) |
| Interest Coverage Ratio: 1.12 > 6 (EBIT TTM 552.7m / Interest Expense TTM 493.0m) |
| A: -0.00 (Total Current Assets 1.43b - Total Current Liabilities 1.57b) / Total Assets 36.3b |
| B: 0.09 (Retained Earnings 3.13b / Total Assets 36.3b) |
| C: 0.02 (EBIT TTM 552.7m / Avg Total Assets 35.8b) |
| D: 0.14 (Book Value of Equity 4.44b / Total Liabilities 31.9b) |
| Altman-Z'' = 0.51 = B |
| DSRI: 1.02 (Receivables 141.7m/142.6m, Revenue 1.96b/2.02b) |
| GMI: 0.96 (GM 69.96% / 72.93%) |
| AQI: 1.20 (AQ_t 0.95 / AQ_t-1 0.79) |
| SGI: 0.97 (Revenue 1.96b / 2.02b) |
| TATA: -0.00 (NI 427.4m - CFO 577.4m) / TA 36.3b) |
| Beneish M = -2.95 (Cap -4..+1) = A |
As of September 27, 2026, the stock is trading at USD 73.85 with a total of 808,847 shares traded. Over the past week, the price has changed by -1.47%, over one month by -0.43%, over three months by +0.11% and over the past year by +20.58%.
Current recommended Stop Loss: 72.00 (which is 2.5% or 1.3 ATR below the current price).
Hancock Whitney has received a consensus analysts rating of 4.50. Therefore, it is recommended to buy HWC.
- StrongBuy: 5
- Buy: 2
- Hold: 1
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 84.4 | 14.3% |
P/E Trailing = 14.4255
P/E Forward = 10.0908
P/S = 4.1787
P/B = 1.3448
P/EG = 1.7575
Revenue TTM = 1.96b USD
EBIT TTM = 552.7m USD
EBITDA TTM = 578.1m USD
Long Term Debt = 193.8m USD (from longTermDebt, last quarter)
Short Term Debt = 1.57b USD (from shortTermDebt, last quarter)
Debt = 2.01b USD (from shortLongTermDebtTotal, last quarter) + Leases 122.5m
Net Debt = 785.4m USD (calculated: Debt 2.01b - CCE 1.22b)
Enterprise Value = 6.69b USD (5.90b + Debt 2.01b - CCE 1.22b)
Interest Coverage Ratio = 1.12 (Ebit TTM 552.7m / Interest Expense TTM 493.0m)
EV/FCF = 11.95x (Enterprise Value 6.69b / FCF TTM 559.7m)
FCF Yield = 8.37% (FCF TTM 559.7m / Enterprise Value 6.69b)
FCF Margin = 28.56% (FCF TTM 559.7m / Revenue TTM 1.96b)
Net Margin = 21.81% (Net Income TTM 427.4m / Revenue TTM 1.96b)
Gross Margin = 72.93% ((Revenue TTM 1.96b - Cost of Revenue TTM 530.5m) / Revenue TTM)
Gross Margin QoQ = 74.36% (prev 68.35%)
Tobins Q-Ratio = 0.18 (Enterprise Value 6.69b / Total Assets 36.3b)
Interest Expense / Debt = 24.53% (Interest Expense 493.0m / Debt 2.01b)
Taxrate = 20.78% (112.1m / 539.5m)
NOPAT = 437.8m (EBIT 552.7m * (1 - 20.78%))
Current Ratio = 0.91 (Total Current Assets 1.43b / Total Current Liabilities 1.57b)
Debt / Equity = 0.45 (Debt 2.01b / totalStockholderEquity, last quarter 4.44b)
Debt / EBITDA = 1.36 (Net Debt 785.4m / EBITDA 578.1m)
Debt / FCF = 1.40 (Net Debt 785.4m / FCF TTM 559.7m)
Total Stockholder Equity = 4.45b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.19% (Net Income 427.4m / Total Assets 36.3b)
RoE = 9.61% (Net Income TTM 427.4m / Total Stockholder Equity 4.45b)
RoCE = 11.90% (EBIT 552.7m / Capital Employed (Equity 4.45b + L.T.Debt 193.8m))
RoIC = 1.21% (NOPAT 437.8m / Invested Capital 36.2b)
WACC = 11.85% (E(5.90b)/V(7.91b) * Re(9.27%) + D(2.01b)/V(7.91b) * Rd(24.53%) * (1-Tc(0.21)))
Discount Rate = 9.27% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -87.95 | Cagr: -2.73%
[DCF] Terminal Value 63.90% ; FCFF base≈563.7m ; Y1≈557.8m ; Y5≈573.8m
[DCF] Fair Price = 60.29 (EV 5.62b - Net Debt 785.4m = Equity 4.84b / Shares 80.2m; r=11.85% [WACC]; 5y FCF grow -1.74% → 2.50% )
EPS Correlation: 71.40 | EPS CAGR: 10.33% | SUE: 0.0 | # QB: 0
Revenue Correlation: 51.22 | Revenue CAGR: 1.68% | SUE: 0.60 | # QB: 0
EPS current Quarter (2026-09-30): EPS=1.66 | Chg30d=-0.46% | Revisions=+0% | Analysts=10
EPS current Year (2026-12-31): EPS=6.46 | Chg30d=-0.47% | Revisions=+22% | GrowthEPS=+12.5% | GrowthRev=+6.6%
EPS next Year (2027-12-31): EPS=7.30 | Chg30d=+0.27% | Revisions=-10% | GrowthEPS=+13.1% | GrowthRev=+9.3%
[Analyst] Revisions Ratio: +5% (up=10, down=9)